Condition
Cardiovascular Calcification
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Terminated1
Completed1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07392697Not ApplicableNot Yet Recruiting
The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease
NCT07344922Phase 3Completed
SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia
NCT07156006Terminated
Breast Arterial Calcifications as an Imaging Biomarker of Cardiovascular Risk
Showing all 3 trials